Home > Research > Researchers > Professor Thomas Jaki > Publications

Professor Thomas Jaki

Formerly at Lancaster University

  1. Journal article
  2. Published

    Using an Interaction Parameter in Model-Based Phase I Trials for Combination Treatments? A Simulation Study

    Mozgunov, P., Knight, R., Barnett, H. & Jaki, T., 5/01/2021, In: International Journal of Environmental Research and Public Health. 18, 1, 19 p., 345.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  3. Published

    Methods for Non-Compartmental Pharmacokinetic Analysis With Observations Below the Limit of Quantification

    Barnett, H. Y., Geys, H., Jacobs, T. & Jaki, T., 2/01/2021, In: Statistics in Biopharmaceutical Research. 13, 1, p. 59-70 12 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  4. Published

    Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs

    Burnett, T., Mozgunov, P., Pallmann, P., Villar, S. S., Wheeler, G. M. & Jaki, T., 19/11/2020, In: BMC Medicine. 18, 1, 21 p., 352.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  5. Published

    An information-theoretic approach for selecting arms in clinical trials

    Mozgunov, P. & Jaki, T. F., 10/11/2020, In: Journal of the Royal Statistical Society: Series B (Statistical Methodology). 82, 5, p. 1223-1247 25 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  6. Published

    Using a Dose-Finding Benchmark to Quantify the Loss Incurred by Dichotomisation in Phase II Dose-Ranging Studies

    Mozgunov, P., Jaki, T. & Paoletti, X., 1/11/2020, In: Biometrical Journal. 62, 7, p. 1717-1729 13 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  7. Published

    Using a dose-finding benchmark to quantify the loss incurred by dichotomization in Phase II dose-ranging studies

    Mozgunov, P., Jaki, T. & Paoletti, X., 1/11/2020, In: Biometrical Journal. 62, 7, p. 1717-1729 13 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  8. Published

    A surface-free design for phase I dual-agent combination trials

    Mozgunov, P., Gasparini, M. & Jaki, T., 1/10/2020, In: Statistical Methods in Medical Research. 29, 10, p. 3093-3109 17 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  9. Published

    A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violation

    Abbas, R., Rossoni, C., Jaki, T., Paoletti, X. & Mozgunov, P., 1/10/2020, In: Clinical Trials. 17, 5, p. 522-534 13 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  10. Published

    Endpoints for randomized controlled clinical trials for COVID-19 treatments

    Dodd, L. E., Follmann, D., Wang, J., Koenig, F., Korn, L. L., Schoergenhofer, C., Proschan, M., Hunsberger, S., Bonnett, T., Makowski, M., Belhadi, D., Wang, Y., Cao, B., Mentre, F. & Jaki, T., 1/10/2020, In: Clinical Trials. 17, 5, p. 472-482 11 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  11. Published

    Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19

    Stallard, N., Hampson, L., Benda, N., Brannath, W., Burnett, T., Friede, T., Kimani, P. K., Koenig, F., Krisam, J., Mozgunov, P., Posch, M., Wason, J., Wassmer, G., Whitehead, J., Williamson, S. F., Zohar, S. & Jaki, T., 1/10/2020, In: Statistics in Biopharmaceutical Research. 12, 4, p. 483-497 15 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

Back to top